Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer

Siegel, 2015, Cancer statistics, 2015, CA Cancer J Clin, 65, 5, 10.3322/caac.21254

DeSantis, 2013, Cancer statistics for African Americans, 2013, CA Cancer J Clin, 63, 151, 10.3322/caac.21173

Sakr, 1993, The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients, J Urol, 150, 379, 10.1016/S0022-5347(17)35487-3

Giacchetti, 1990, Characterization in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells, Int J Cancer, 46, 293, 10.1002/ijc.2910460226

Reubi, 2002, Bombesin receptor subtypes in human cancers: Detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14), Clin Cancer Res, 8, 1139

Toi-Scott, 1996, Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells, Lung Cancer, 15, 341, 10.1016/0169-5002(95)00597-8

Patel, 2006, Gastrin-releasing peptide and cancer, Biochim Biophys Acta, 1766, 23

, 2013, Handbook of biologically active peptides, 2, 506

Cuttitta, 1985, Autocrine growth factors in human small cell lung cancer, Cancer Surv, 4, 707

Lango, 2002, Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck, J Natl Cancer Inst, 94, 375, 10.1093/jnci/94.5.375

Plonowski, 2000, In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215, Int J Cancer, 88, 652, 10.1002/1097-0215(20001115)88:4<652::AID-IJC21>3.0.CO;2-1

Sharif, 1997, Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway, Mol Cell Endocrinol, 130, 119, 10.1016/S0303-7207(97)00080-4

Wang, 1996, Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway, Int J Cancer, 68, 528, 10.1002/(SICI)1097-0215(19961115)68:4<528::AID-IJC20>3.0.CO;2-#

Oliveira-Freitas, 2015, RC-3095, a selective gastrin-releasing peptide receptor antagonist, does not protect the lungs in an experimental model of lung ischemia-reperfusion injury, Biomed Res Int, 2015, 496378, 10.1155/2015/496378

Jensen, 1978, Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells, Proc Natl Acad Sci USA, 75, 6139, 10.1073/pnas.75.12.6139

Katsuno, 1999, Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R), Biochemistry, 38, 7307, 10.1021/bi990204w

Preston, 1996, Bombesin-like peptides and cancer, Crit Rev Oncol Hematol, 23, 225, 10.1016/1040-8428(96)00204-1

Aprikian, 1998, Neuroendocrine differentiation and the bombesin/gastrin-releasing peptide family of neuropeptides in the progression of human prostate cancer, Prostate Suppl, 8, 52, 10.1002/(SICI)1097-0045(1998)8+<52::AID-PROS9>3.0.CO;2-I

Lee, 2001, Neuropeptide-induced androgen independence in prostate cancer cells: Roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase, Mol Cell Biol, 21, 8385, 10.1128/MCB.21.24.8385-8397.2001

Levine, 2003, Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells, Cancer Res, 63, 3495

LeRoy, 2006, New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft, Prostate, 66, 1213, 10.1002/pros.20408

Liao, 2008, Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions, Int J Cancer, 123, 2267, 10.1002/ijc.23602

Li, 2011, Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone, Bone, 48, 1354, 10.1016/j.bone.2011.03.687

Wise-Milestone, 2012, Evaluating the effects of mixed osteolytic/osteoblastic metastasis on vertebral bone quality in a new rat model, J Orthop Res, 30, 817, 10.1002/jor.21577

Thudi, 2011, Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases, Prostate, 71, 615, 10.1002/pros.21277

Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262

Markwalder, 1999, Gastrin-releasing peptide receptors in the human prostate: Relation to neoplastic transformation, Cancer Res, 59, 1152

Korner, 2014, Early over-expression of GRP receptors in prostatic carcinogenesis, Prostate, 74, 217, 10.1002/pros.22743

Ananias, 2009, Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer, Prostate, 69, 1101, 10.1002/pros.20957

Simmons, 2014, Review of animal models of prostate cancer bone metastasis, Vet Sci, 16, 10.3390/vetsci1010016

Halvorson, 2005, A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone, Cancer Res, 65, 9426, 10.1158/0008-5472.CAN-05-0826

Halvorson, 2006, Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer, Clin J Pain, 22, 587, 10.1097/01.ajp.0000210902.67849.e6

Brabletz, 2001, Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment, Proc Natl Acad Sci USA, 98, 10356, 10.1073/pnas.171610498

Brabletz, 2005, Opinion: Migrating cancer stem cells-An integrated concept of malignant tumour progression, Nat Rev Cancer, 5, 744, 10.1038/nrc1694

Hollier, 2009, The epithelial-to-mesenchymal transition and cancer stem cells: A coalition against cancer therapies, J Mammary Gland Biol Neoplasia, 14, 29, 10.1007/s10911-009-9110-3

Hugo, 2007, Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression, J Cell Physiol, 213, 374, 10.1002/jcp.21223

Christiansen, 2006, Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis, Cancer Res, 66, 8319, 10.1158/0008-5472.CAN-06-0410

Aigner, 2007, The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity, Oncogene, 26, 6979, 10.1038/sj.onc.1210508

Guarino, 2007, The role of epithelial-mesenchymal transition in cancer pathology, Pathology, 39, 305, 10.1080/00313020701329914

Hayward, 2000, The prostate: Development and physiology, Radiol Clin North Am, 38, 1, 10.1016/S0033-8389(05)70146-9

Marker, 2003, Hormonal, cellular, and molecular control of prostatic development, Dev Biol, 253, 165, 10.1016/S0012-1606(02)00031-3

Prins, 2008, Molecular signaling pathways that regulate prostate gland development, Differentiation, 76, 641, 10.1111/j.1432-0436.2008.00277.x

Santos, 2015, Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements, Oncoscience, 2, 497, 10.18632/oncoscience.142

Weber, 1985, Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro, J Clin Invest, 75, 306, 10.1172/JCI111690

Hoosein, 1993, Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells, J Urol, 149, 1209, 10.1016/S0022-5347(17)36349-8

Nagakawa, 2001, Effect of prostatic neuropeptides on migration of prostate cancer cell lines, Int J Urol, 8, 65, 10.1046/j.1442-2042.2001.00250.x

Bold, 1998, A human gastric cancer cell line possesses a functional receptor for gastrin-releasing peptide, Cancer Invest, 16, 12, 10.3109/07357909809039748

Bold, 1994, Bombesin stimulates the in vitro growth of a human gastric cancer cell line, J Cell Physiol, 161, 519, 10.1002/jcp.1041610315

Avis, 1993, Effect of gastrin-releasing peptide on the pancreatic tumor cell line (Capan), Mol Carcinog, 8, 214, 10.1002/mc.2940080403

Iishi, 1992, Enhancement by bombesin of colon carcinogenesis and metastasis induced by azoxymethane in Wistar rats, Int J Cancer, 50, 834, 10.1002/ijc.2910500529

Ishola, 2007, Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells, Biochim Biophys Acta, 1770, 927, 10.1016/j.bbagen.2007.02.002

Flores, 2008, Gastrin-releasing peptide receptors regulate proliferation of C6 Glioma cells through a phosphatidylinositol 3-kinase-dependent mechanism, Curr Neurovasc Res, 5, 99, 10.2174/156720208784310240

de Oliveira, 2009, Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models, J Neurooncol, 93, 191, 10.1007/s11060-008-9775-2

Taylor, 2010, Integrative genomic profiling of human prostate cancer, Cancer Cell, 18, 11, 10.1016/j.ccr.2010.05.026

Gregory, 2001, A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy, Cancer Res, 61, 4315

Agoulnik, 2006, Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer, Cancer Res, 66, 10594, 10.1158/0008-5472.CAN-06-1023

Xiao, 2003, Activation of extracellular signal-regulated kinase mediates bombesin-induced mitogenic responses in prostate cancer cells, Cell Signal, 15, 945, 10.1016/S0898-6568(03)00059-7

Zhang, 2004, SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells, Cancer Res, 64, 6166, 10.1158/0008-5472.CAN-04-0504

Zhang, 2006, Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation, Proc Natl Acad Sci USA, 103, 6901, 10.1073/pnas.0509719103

Lee, 2012, FAK is a critical regulator of neuroblastoma liver metastasis, Oncotarget, 3, 1576, 10.18632/oncotarget.732

Patel, 2014, Galpha13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration, Mol Pharmacol, 86, 252, 10.1124/mol.114.093914

Chao, 2009, Gastrin-releasing peptide receptor in breast cancer mediates cellular migration and interleukin-8 expression, J Surg Res, 156, 26, 10.1016/j.jss.2009.03.072

Arboleda, 2003, Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells, Cancer Res, 63, 196

Li, 2012, Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion, PLoS ONE, 7, e39766, 10.1371/journal.pone.0039766

Pohorelic, 2012, Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment, Breast Cancer Res Treat, 133, 201, 10.1007/s10549-011-1753-2

Stangelberger, 2005, Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice, Clin Cancer Res, 11, 49, 10.1158/1078-0432.49.11.1

Zhang, 2001, Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone, J Clin Invest, 107, 1235, 10.1172/JCI11685

McKee, 2005, Hierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeleton, Cells Tissues Organs, 181, 176, 10.1159/000091379

Seretis, 2001, Comparative study of serotonin and bombesin in adenocarcinomas and neuroendocrine tumors of the colon, Ultrastruct Pathol, 25, 445, 10.1080/019131201753343485

Ishimaru, 2002, Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases, Acta Oncol, 41, 289, 10.1080/02841860260088845